Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity.
about
The neurobiology of the Prader-Willi phenotype of fragile X syndromeNovel strategies for anti-aging drug discovery.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis.Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial.Targeting glucose metabolism for healthy aging.
P2860
Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Comparison of acarbose and met ...... ith overweight and/or obesity.
@en
Comparison of acarbose and met ...... ith overweight and/or obesity.
@nl
type
label
Comparison of acarbose and met ...... ith overweight and/or obesity.
@en
Comparison of acarbose and met ...... ith overweight and/or obesity.
@nl
prefLabel
Comparison of acarbose and met ...... ith overweight and/or obesity.
@en
Comparison of acarbose and met ...... ith overweight and/or obesity.
@nl
P2093
P2860
P1476
Comparison of acarbose and met ...... ith overweight and/or obesity.
@en
P2093
Chunping Zeng
Lizhen Liao
P2860
P304
P356
10.1080/03007995.2016.1176013
P407
P50
P577
2016-04-07T00:00:00Z